Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences

Neural Plasticity
Gloria Ortiz-GuerreroMauricio Orlando Nava Mesa

Abstract

Alzheimer's disease (AD) is the most common type of dementia, mainly encompassing cognitive decline in subjects aged ≥65 years. Further, AD is characterized by selective synaptic and neuronal degeneration, vascular dysfunction, and two histopathological features: extracellular amyloid plaques composed of amyloid beta peptide (Aβ) and neurofibrillary tangles formed by hyperphosphorylated tau protein. Dementia and AD are chronic neurodegenerative conditions with a complex physiopathology involving both genetic and environmental factors. Recent clinical studies have shown that proton pump inhibitors (PPIs) are associated with risk of dementia, including AD. However, a recent case-control study reported decreased risk of dementia. PPIs are a widely indicated class of drugs for gastric acid-related disorders, although most older adult users are not treated for the correct indication. Although neurological side effects secondary to PPIs are rare, several preclinical reports indicate that PPIs might increase Aβ levels, interact with tau protein, and affect the neuronal microenvironment through several mechanisms. Considering the controversy between PPI use and dementia risk, as well as both cognitive and neuroprotective effects, the a...Continue Reading

References

Nov 1, 1992·Clinical Pharmacology and Therapeutics·R A LefebvreE Van Ganse
May 13, 1992·Molecular and Cellular Biochemistry·G A FaríasR B Maccioni
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Apr 28, 1990·Lancet·P L McGeerJ Sibley
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K S KosikD J Selkoe
Oct 1, 1995·Physiological Reviews·R B Maccioni, V Cambiazo
Dec 1, 1995·Clinical and Experimental Pharmacology & Physiology·I R van Driel, J M Callaghan
Aug 1, 1996·British Journal of Clinical Pharmacology·R GuglerU Klotz
Jul 1, 1997·Experimental Gerontology·G N Shah, A D Mooradian
Oct 28, 1998·Journal of Physiology, Paris·S G Younkin
Mar 4, 2000·Journal of Neurology·J G HeckmannB Neundörfer
Nov 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nobuyuki OkamuraYukitsuka Kudo
Sep 6, 2006·The American Journal of Gastroenterology·Joel J Heidelbaugh, John M Inadomi
Dec 11, 2007·Archives of Medical Research·Leonel E RojoRicardo B Maccioni
Apr 16, 2008·The American Journal of Emergency Medicine·Vikhyat S BebartaMarie McDonough
May 3, 2008·Journal of Clinical Pharmacy and Therapeutics·M R Namazi, F Jowkar
Jun 10, 2008·Pflügers Archiv : European journal of physiology·Jai Moo ShinGeorge Sachs
Mar 26, 2009·Acta Neuropathologica·Robert D Bell, Berislav V Zlokovic
Jul 4, 2009·The Journal of Clinical Psychiatry·Cynthia M StonningtonRichard J Caselli
Dec 1, 2009·Brain Research Reviews·Michael T HenekaAlexei Verkhratsky
Dec 17, 2009·Acta Neuropathologica·Michael V Sofroniew, Harry V Vinters
Jan 12, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lucio LombardoAndrea Chiecchio
Jan 12, 2010·Biochemical Pharmacology·Andrea A CronicanIliya Lefterov
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·M K FallahzadehM R Namazi
Jul 17, 2010·Current Opinion in Structural Biology·Maike BublitzPoul Nissen
Dec 22, 2010·Neuron·Lucia Tabares, Bill Betz
Oct 29, 2011·Journal of Epidemiology and Community Health·John GallacherYoav Ben-Shlomo
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Eva-Maria Mandelkow, Eckhard Mandelkow
Jul 6, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Teodoro BottiglieriEstelle Sontag

❮ Previous
Next ❯

Citations

May 31, 2019·Journal of Gastroenterology and Hepatology·Sun-Kyeong ParkJu-Young Shin
Jul 25, 2019·Journal of Gastroenterology and Hepatology·Salman HussainAbul Kalam Najmi
Jun 2, 2020·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·Madhav DesaiPrateek Sharma
Jun 18, 2020·Brain Sciences·Gloria Ortiz-GuerreroMauricio O Nava-Mesa
Sep 12, 2018·Journal of Clinical Medicine·Wei-Te HungChao-Bin Yeh
Sep 27, 2018·American Journal of Alzheimer's Disease and Other Dementias·Ahmet Turan Isik, Pinar Soysal
Aug 9, 2019·Journal of Neuro-oncology·Mohammed AlbatanyRobert Bartha
Apr 14, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H CetinE Stögmann
Jan 15, 2021·European Journal of Clinical Pharmacology·Nayeon AhnIna-Maria Rückert-Eheberg
Dec 31, 2020·Therapeutics and Clinical Risk Management·Carlos-Alberto Calderon-OspinaAna María Paez-Hurtado
Mar 3, 2021·Applied Neuropsychology. Adult·Brian George CollinSteve Katsikas
Feb 23, 2021·Curēus·Marcel YibirinSophia Lutgen
Mar 27, 2021·Current Gastroenterology Reports·Eugene StolowSandeep Patel
Nov 24, 2020·Semergen·G M Saiz LaderaJ N García Pascual
Aug 28, 2021·Cells·Julia Murciano-BreaCelia Herrera-Rincon
Jul 27, 2021·Journal of Pediatric Gastroenterology and Nutrition·Marta Tavares, Jorge Amil-Dias
Nov 24, 2021·European Journal of Clinical Pharmacology·Hengmin WangXiaohong Yan

❮ Previous
Next ❯

Methods Mentioned

BETA
circular dichroism

Software Mentioned

CANTAB

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Related Papers

International Journal of Alzheimer's Disease
A AnoopSamir K Maji
Molecular Neurodegeneration
Maud GratuzeDavid M Holtzman
Current Alzheimer Research
Robert A WhittingtonEmmanuel Planel
© 2022 Meta ULC. All rights reserved